Revolution Medicines Inc. (NASDAQ:RVMD) is one of the 10 Stocks With Monster Returns.
Revolution Medicines soared by 54.13 percent week-on-week, with sentiment primarily bolstered by the stellar results of its clinical trial for its pancreatic cancer treatment, while taking heart from bullish recommendations from analysts.
In an updated report, Revolution Medicines Inc. (NASDAQ:RVMD) said that its therapy candidate, Daraxonrasib, recorded a median overall survival of 13.2 months during its late-stage clinical study, as compared with 6.7 months for chemotherapy alone.
Photo by RDNE on Pexels
“Daraxonrasib, as a targeted medicine, delivered a dramatic improvement in overall survival in patients with previously treated metastatic pancreatic cancer compared to standard of care chemotherapy, consistent with earlier findings. These results represent a potentially transformative advance for patients and underscore daraxonrasib’s potential to redefine the treatment landscape,” Revolution Medicines Inc. (NASDAQ:RVMD) Chairman and CEO Mark Goldsmith said.
Following the results, the company said that it is now “moving with urgency” toward global regulatory submissions, including the filing of a new drug application with the Food and Drug Administration (FDA).
Revolution Medicines Inc. (NASDAQ:RVMD) earned a “strong buy” recommendation from investment firm Raymond James, alongside a 30-percent price target hike of $175, versus $135 previously.
Meanwhile, Bank of America gave a $170 price target, or a 48 percent upgrade from $115, while maintaining a “buy” recommendation.
Jim Cramer, former hedge fund manager and host of the Mad Money show on CNBC, underscored the company’s slashing of death risk by 60 percent.
“That’s rather extraordinary. And … they’re gonna seek FDA approval, Commissioner’s national priority voucher. But what matters here is that Merck, just reportedly, was trying to buy it for $28 to $32 billion, well in excess of what they wanted to buy it, so, you could argue, why did they buy it?”
While we acknowledge the risk and potential of RVMD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RVMD and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.